Prostate Cancer
Conditions
Keywords
Screening, Shared Decision Making
Brief summary
The study team created a tool to help identify patients who may benefit from shared decision making in the primary care setting. This tool is a guide to aid in decision making for prostate cancer screening. The team proposes the topics to be discussed in the screening conversation include the risk for developing prostate cancer based upon age, race/ethnicity, family history of prostate cancer, history of previous digital rectal exam, and history of previous prostate specific antigen (PSA) as well as self-reported health status and preferences for treatment. The team now proposes 1) testing this tool first for ease of use in primary care clinics 2) revising this tool based upon feedback from patients and providers, then 3) testing this tool for effectiveness in improving patient knowledge that they have an option to be screened for prostate cancer and of specific factors to be considered in the screening decision.
Detailed description
Objectives: 1. To pilot test a decision making tool, the PSA TOOL, for prostate cancer screening for usefulness and ease of use in primary care practices. 2. To revise the PSA TOOL based upon provider and patient feedback. 3. To assess patient knowledge about the option to be screened for prostate cancer and factors to consider in the prostate cancer screening decision before and after use of the tool. Study Design: This protocol is for field testing of a brief tool to improve prostate cancer screening discussions that occur at previously scheduled primary care outpatient visits.
Interventions
BEHAVIORALPSA TOOL
Providers will be given the initial PSA TOOL and will be asked to give their feedback to revise the tool.
BEHAVIORALRevised PSA TOOL
Patients will be given the revised PSA TOOL, after providers have given their initial feedback.
BEHAVIORALInformal Interview
Both patients and providers will have informal interviews with the study team to get feedback on the survey taking process.
Sponsors
Case Comprehensive Cancer Center
Study design
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
Initially, health care providers will give feedback on the tool. The tool will be revised and the second segment of the study will be to give the revised tool to patients with pre- and post-tests which measure changes in prostate cancer screening knowledge.
Eligibility
Sex/Gender
MALE
Age
40 Years to 69 Years
Healthy volunteers
Yes
Inclusion criteria
Provider: * Provider at selected primary care practices in the Cleveland Clinic Health System * Willing to utilize a guide to aid in decision making for prostate cancer screening Patient: \- Patient of participating Cleveland Clinic primary care provider who is scheduled for a routine appointment with the provider
Exclusion criteria
* Not a patient or provider of the Cleveland Clinic Health System
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Score from Perceived Usefulness scale | Up to 4 weeks after getting PSA TOOL | scale will be summarized as means and standard deviations |
| Score from Perceived Ease of Use scale | Up to 4 weeks after getting PSA TOOL | scale will be summarized as means and standard deviations |
| Change in Score from Pre-Test to Post-Test | Up to 30 minutes after Pre-Test | The paired t-test will be used to compare the pre- and post- patient survey scores |
Other
| Measure | Time frame | Description |
|---|---|---|
| Informal Interview | Up to 15 minutes after post test is performed | Informal interviews will be done with patients and providers and assessed for themes |
Countries
United States
Outcome results
None listed